<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>6(1)</volume><submitter>Okwan-Duodu D</submitter><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Institute of Allergy and Infectious Diseases</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Heart, Lung, and Blood Institute</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)</funding><journal>Signal transduction and targeted therapy</journal><pagination>100</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7919249</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>TMPRSS2 activity may mediate sex differences in COVID-19 severity.</pubmed_title><pmcid>PMC7919249</pmcid><funding_grant_id>AI144529</funding_grant_id><funding_grant_id>HL141638</funding_grant_id><pubmed_authors>Engman DM</pubmed_authors><pubmed_authors>Lim EC</pubmed_authors><pubmed_authors>Okwan-Duodu D</pubmed_authors><pubmed_authors>You S</pubmed_authors></additional><is_claimable>false</is_claimable><name>TMPRSS2 activity may mediate sex differences in COVID-19 severity.</name><description/><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Mar</publication><modification>2025-04-04T12:24:22.786Z</modification><creation>2025-04-04T12:24:22.786Z</creation></dates><accession>S-EPMC7919249</accession><cross_references><pubmed>33649313</pubmed><doi>10.1038/s41392-021-00513-7</doi></cross_references></HashMap>